Salidroside targeted cytosolic phospholipase A2 and regulated arachidonic acid metabolomics to attenuate atherosclerosis progression

Salidroside targeted cytosolic phospholipase A2 and regulated arachidonic acid metabolomics to attenuate atherosclerosis progression

Lipid metabolism disturbances are linked to the development of atherosclerosis (AS), with arachidonic acid (AA) and other downstream metabolites being involved. Cytosolic phospholipase A2 (cPLA2) is a key restriction enzyme in AA metabolism. Salidroside (SAL) reportedly alleviates AS by inhibiting i...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing Liao, Yihua Wang, Rong Huang, Ailu Deng, Han Xu, Wen Guo, Dan Wen, Tianqin Xia, Jiaojiao Bian, Zhengmin Xu, Chunyang Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:All Life
Subjects:
salidroside
atherosclerosis
cpla2
arachidonic acid
Online Access:http://dx.doi.org/10.1080/26895293.2025.2515449
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items